ROBOT‐assisted pancreatoduodenectomy in 300 consecutive cases: Annual trend analysis and propensity score‐matched comparison of perioperative and long‐term oncologic outcomes with the open method
- 24 October 2021
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 29 (3) , 301-310
Abstract
Background/Purpose: We previously reported perioperative and oncologic outcomes of robot‐assisted pancreatoduodenectomy (RAPD); however, the follow‐up period in RAPD was relatively short, and disease‐matched survival analyses were lacking. Therefore, this study investigated time trends of perioperative and long‐term disease‐matched outcomes of RAPD.Methods: Annual clinicopathologic outcomes of 328 patients with RAPD between 2015 and 2020 were analyzed and compared with 929 patients with open PD using the propensity score‐matched (PSM) analysis based on postoperative pancreatic fistula (POPF) risk and oncologic variables in malignant patients.Results: Robot‐assisted pancreatoduodenectomy cases increased from 10 (6.3%) in 2015 to 116 (50.2% of total PD) in 2020, with malignancy proportion increasing from 50.0% to 80.2%. POPF risk‐based PSM analysis showed that compared with open PD, RAPD had younger patients (63.7 vs 65.6 years, P = .018), longer operation time (339.1 vs 290.0 min, P < .001); however, estimated blood loss (P = .275), complications (17.1% vs 18.3%, P = .702), and clinically relevant POPF (9.8% vs 11.1%, P = .584) were similar with shorter postoperative hospital stay (10.8 vs 15.6 days, P < .001). In disease and stage‐matched malignant patients, R0 resection (93.9% vs 91.2%, P = .376), total retrieved lymph node (18.2 vs 19.9, P = .058), and 5‐year survival rate (57.3% vs 60.6%, P = .406) were similar between RAPD and open PD, also in pancreatic cancer patients (31.6% vs 26.3%, P = .068).Conclusions: Robot‐assisted pancreatoduodenectomy demonstrated similar perioperative outcomes with earlier recovery and equivalent long‐term survival with open PD. RAPD is safe and feasible for periampullary lesions, including pancreatic cancers, and its role will expand in the era of minimally invasive surgery.Keywords
This publication has 19 references indexed in Scilit:
- Multicenter outcomes of robotic reconstruction during the early learning curve for minimally-invasive pancreaticoduodenectomyHPB, 2018
- Comparison of surgical outcomes between open and robot‐assisted minimally invasive pancreaticoduodenectomyJournal of Hepato-Biliary-Pancreatic Sciences, 2017
- Early experience of laparoscopic and robotic hybrid pancreaticoduodenectomyThe International Journal of Medical Robotics and Computer Assisted Surgery, 2017
- Worldwide survey on opinions and use of minimally invasive pancreatic resectionHPB, 2017
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years AfterSurgery, 2017
- Robot-assisted laparoscopic versus open pancreaticoduodenectomy: a prospective, matched, mid-term follow-up studySurgical Endoscopy, 2015
- A Prospectively Validated Clinical Risk Score Accurately Predicts Pancreatic Fistula after PancreatoduodenectomyJournal of the American College of Surgeons, 2013
- Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population DatabaseAnnals of Surgical Oncology, 2006
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Laparoscopic pylorus-preserving pancreatoduodenectomySurgical Endoscopy, 1994